EI
DNLI icon

Ellevest Inc’s Denali Therapeutics DNLI Stock Holding History

Ellevest Inc’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-119
Closed -$3.31K – 1941
2022
Q4 		$3.31K Buy
+119
New +$3.54K ﹤0.01% 1284
2022
Q2 		– Sell
-3
Closed – – 1458
2022
Q1 		$0 Sell
3
-8
-73% -$275 ﹤0.01% 1470
2021
Q4 		$0 Sell
11
-4
-27% -$190 ﹤0.01% 1472
2021
Q3 		$1K Sell
15
-14
-48% -$789 ﹤0.01% 1250
2021
Q2 		$2K Sell
29
-3
-9% -$186 ﹤0.01% 1026
2021
Q1 		$2K Buy
32
+5
+19% +$335 ﹤0.01% 1047
2020
Q4 		$2K Buy
27
+16
+145% +$967 ﹤0.01% 961
2020
Q3 		$0 Buy
+11
New +$331 ﹤0.01% 1169
2020
Q2 		– Sell
-33
Closed -$1K – 1172
2020
Q1 		$1K Hold
33
– – ﹤0.01% 866
2019
Q4 		$1K Buy
+33
New +$549 ﹤0.01% 756

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return